On January 5, 2026, MetaVia, Inc. (NASDAQ:MTVA) announced positive and statistically significant results from the 8-week 48 mg cohort from the Phase 1b trial of DA-1726, the company’s dual ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

MetaVia ( (MTVA)) has provided an announcement. On January 15–16, 2026, MetaVia Inc. completed an underwritten public offering of Class A and Class B units, consisting of common stock, pre-funded ...

One person died and another person was injured in a three-vehicle crash in Eagan on Friday night, officials said. At 5:15 p.m. Friday, Eagan police were called to a three-vehicle collision at Pilot ...

CAMBRIDGE, Mass. - MetaVia Inc. (NASDAQ:MTVA) announced Monday positive results from the extended 8-week trial of its experimental obesity treatment DA-1726, showing multiple metabolic improvements in ...

MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity, and is developing ...

CAMBRIDGE, Mass. - MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company with a market capitalization of just under $19 million, announced Monday that it has regained compliance with ...

MetaVia ( (MTVA)) just unveiled an announcement. On May 29, 2025, MetaVia Inc. was notified by Nasdaq that it was not in compliance with the exchange’s $1.00 minimum bid price requirement after its ...

Bukarest, december 8./Agerpres - A Nemzeti Liberális Párt (PNL) elnöke, Ilie Bolojan hétfőn gratulált a Facebook-oldalán Ciprian Ciucunak a bukaresti főpolgármesteri tisztség elnyeréséhez.

The average one-year price target for MetaVia (NasdaqCM:MTVA) has been revised to $159.88 / share. This is an increase of 1,000.00% from the prior estimate of $14.54 dated November 14, 2025. The price ...

CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- MetaVia Inc. (MTVA) ("MetaVia" or the "Company"), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today ...